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Purpose: It has been demonstrated that mutations in deafness, autosomal recessive 31 (DFNB31), the gene encoding
whirlin, is responsible for nonsyndromic hearing loss (NSHL; DFNB31) and Usher syndrome type II (USH2D). We
screened DFNB31 in a large cohort of patients with different clinical subtypes of Usher syndrome (USH) to determine
the prevalence of DFNB31 mutations among USH patients.
Methods: DFNB31 was screened in 149 USH2, 29 USH1, six atypical USH, and 11 unclassified USH patients from
diverse ethnic backgrounds. Mutation detection was performed by direct sequencing of all coding exons.
Results: We identified 38 different variants among 195 patients. Most variants were clearly polymorphic, but at least two
out of the 15 nonsynonymous variants (p.R350W and p.R882S) are predicted to impair whirlin structure and function,
suggesting eventual pathogenicity. No putatively pathogenic mutation was found in the second allele of patients with these
mutations.
Conclusions: DFNB31 is not a major cause of USH.
Usher  syndrome  (OMIM  276900–2;  OMIM  276905;
OMIM  605472)  is  the  most  common  cause  of  genetic
deafblindness. This syndrome follows an autosomal recessive
pattern  of  inheritance  and  is  characterized  by  retinitis
pigmentosa (RP), sensorineural hearing impairment, and in
some cases vestibular dysfunction. Three clinical types can be
distinguished  [1].  Patients  with  Usher  syndrome  type  I
(USH1) show severe to profound congenital hearing loss,
early onset RP, and vestibular areflexia. Patients with type II
(USH2) suffer from moderate to severe congenital hearing
loss, onset of RP around puberty or in adulthood, but normal
vestibular function. Usher type III (USH3) patients present
with progressive hearing loss, RP, and variable vestibular
function. Furthermore, some Usher syndrome patients cannot
be  classified  into  any  of  these  three  subtypes  and  are
considered atypical Usher (USHA) patients. To date, nine
genes are known to be involved in USH: MYO7A (USH1B),
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USH1C, CDH23 (USH1D), PCDH15 (USH1F), and USH1G
for USH1; USH2A,GPR98 (USH2C), and DFNB31 (USH2D)
for USH2; and USH3A for USH3 [2-14]. The eight genes
responsible for USH1 and USH2 encode proteins that interact
in a functional network.
The DFNB31 gene was initially found to be responsible
for recessive nonsyndromic sensorineural hearing impairment
(NSHI),  underlying  the  DFNB31  locus  [15].  DFNB31
comprises 12 exons and encodes the whirlin protein. Two
isoforms of whirlin are known. The short isoform is encoded
by exons 6–12 and contains one PDZ domain (PDZ3) and a
proline-rich region. The long isoform is encoded by all 12
DFNB31  exons  and  contains  three  PDZ  domains  (PDZ1,
PDZ2, and PDZ3) and a proline-rich region [15]. PDZ1 and
PDZ2 have been shown to interact with usherin, myosin VIIa,
G-Protein coupled Receptor 98 (GPR98), Scaffold protein
containing Ankyrin repeats and SAM domain (SANS), and
myosin XVa, while PDZ3 interacts only with myosin XVa
[16-18].  All  these  findings  made  DFNB31  an  excellent
candidate for Usher syndrome. More recently, Ebermann et
al. [14] described a novel genetic subtype for Usher syndrome
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495type II (USH2D) caused by truncating mutations in the long
isoform of whirlin.
The protein whirlin is thought to play an important role
in the elongation of stereocilia and development of cochlear
hair cells and has been demonstrated to be the major scaffold
protein of an Usher protein network in the ankle link complex
of inner hair cells [15,17,19]. In the retina, whirlin is a key
partner of another USH interactome in the periciliary region
of  photoreceptor  cells.  This  Usher  protein  network  is
hypothesized  to  be  essential  for  the  regulation  of  cargo
transfer from the photoreceptor inner segment to the outer
segment by the ciliary transport system [18].
The  recent  finding  that  mutations  in  DFNB31  cause
USH2 prompted us to screen the 12 exons of this gene in 195
patients from diverse origins who have USH1, USH2, and
USHA. Our aim was to elucidate the prevalence of DFNB31
mutations in the pathogenesis of USH.
METHODS
Patients: We included 149 patients with USH2, 29 patients
with  USH1,  and  six  patients  with  USHA  in  this  study.
Furthermore,  11  unclassified  USH  patients  were  included
from  whom  clinical  data  were  not  available.  Of  the  195
unrelated patients, 74 were of Spanish origin, 47 of German,
39 of Dutch, 17 of Hungarian, and 13 of other different origins
(see Table 1).
Most  of  these  patients  were  selected  for  DFNB31
screening  after  discarding  the  presence  of  pathologic
mutations  in  the  most  prevalent  USH  genes.  Of  the  195
patients, 116 patients correspond to those briefly mentioned
in  previous  studies  [13,16].  Clinical  diagnosis  of  Usher
syndrome  patients  was  performed  in  different  hospitals
according to standard ophthalmologic, otorhinolaryngologic,
and  electroretinographic  procedures.  Written  informed
consent was obtained for each participant, and the study was
approved by the review board of the Ethics Committee of each
institution that participated in this work.
Mutation screening: Venous blood samples were obtained
and genomic DNA was extracted by standard protocols [7].
For mutation analysis of DFNB31, the 12 coding exons were
PCR amplified using primers located in flanking introns and
untranslated region (UTR) sequences (Table 2). PCR products
were directly sequenced using standard procedures (Table 2).
The obtained sequences were compared with the consensus
sequence NM_015404.
Isocoding and missense changes found in a low frequency
were analyzed with the program RESCUE-ESE (Christopher
Burge Laboratory, Massachusetts Institute of Technology;
Cambridge,  MA).  This  program  predicts  the  creation  or
elimination of exonic splicing enhancer sites (ESEs).
To assess the effect of the amino acid substitutions on the
protein and to study the degree of interspecies amino acid
conservation we used the software Alamut v1.5 Interactive
Biosoftware (Rouen, France).
Intronic,  isocoding,  and  missense  changes  were  also
analyzed  using  the  programs  NNSPLICE  (Berkeley
Drosophila Genome Project [BDGP] University of California
Berkeley;  Berkeley,  CA)  and  Splice  View  (Institute  of
Biomedical Technologies, Milano, Italy) to predict if those
changes could be affecting, creating, or eliminating donor/
acceptor splice sites.
RESULTS
Mutation  screening  of  DFNB31  in  195  USH  patients  of
diverse origins identified 38 different sequence variants: eight
synonymous, 15 missense, and 15 intronic variants. Most of
these changes are clearly polymorphic as they were detected
in high frequencies and represent known single nucleotide
polymorphisms  (SNPs).  Twelve  sequence  variants  were
found only once in our series, five changes were found twice,
one variant was identified in three alleles, and another one in
four (see Table 3). None of these 19 rare changes were found
in the homozygous state or in trans to another putatively
pathogenic variation.
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TABLE 1. CLINICAL CLASSIFICATION OF USH PATIENTS.
Origin USH1 USH2 USHA USH NC* Total
The Netherlands 0 27 2 10 39
Spain 21 51 2 0 74
Germany 2 44 0 1 47
Hungary 2 13 2 0 17
Canada 1 4 0 0 5
Russia 1 2 0 0 3
Arabia 0 1 0 0 1
Egypt 2 2 0 0 4
Turkey 0 3 0 0 3
Unknown 0 2 0 0 2
Total 29 149 6 11 195
*USH NC: Clinical data not available to classify the patients into any subtype.Isocoding changes: Only three out of the eight silent
changes were found with an allele frequency ≤0.01 (see Table
3 for more details). Variant c.1486C>T was only found in one
USH2  patient  from  uncertain  origin,  and  c.2307C>T  was
found in one USH1 patient from Spain and in one USH2
patient from Germany. Variant c.1455G>A was detected in
four alleles of patients from the Netherlands and Germany.
These three rare isocoding variants were analyzed using the
RESCUE-ESE program, but none were found to create or
eliminate any ESEs.
These three changes were also analyzed with NNSPLICE
and Splice View. Both programs predicted the creation of one
new  donor  site  when  introducing  the  change  c.2307C>T
(NNSPLICE score of 0.66 [0.00–1.00] and Splice View score
of 86 [0–100])
Missense  changes:  From  the  15  missense  variants
detected,  only  p.T77S,  p.R350W,  p.T383N,  p.T383S,
p.D447H, p.S628R, p.S648Y, p.M723I, and p.R882S showed
a frequency ≤0.01 (see Table 3).
These  nine  variants  were  analyzed  using  the  Alamut
program. For two of these changes (p.R350W and p.R882S),
this  program  predicted  possible  implications  in  protein
structure and function. The amino acid substitution p.R350W
(c.1048C>T) affected a highly conserved nucleotide at the
cDNA  level  with  a  score  of  0.9  (0–1).  The  amino  acid
conservation  among  13  species  was  moderate,  and  the
Grantham distance between amino acids Arg and Trp was 101
(0–215). Furthermore, this variation was found to be located
in  the  PDZ2  protein  domain.  The  change  p.R882S  (c.
2644C>A  at  the  cDNA  level)  affects  a  highly  conserved
nucleotide  (score  1.0  [0–1])  and  an  amino  acid  highly
conserved up to the fruit fly (considering 13 species). The
physicochemical difference between Arg and Ser was found
to be moderate since a Grantham distance of 110 (0–215) was
obtained. Also this variation was located in the PDZ3 domain.
These nine rare missense variants were further evaluated
for  an  effect  on  exonic  splice  enhancers  by  using  the
RESCUE-ESE program. The change c.1148C>A (p.T383N),
found in two unrelated USH2 patients from the Netherlands,
creates  four  new  putative  ESE  sites,  whereas  c.1339G>A
(p.D447H),  detected  in  one  USH2  patient  from  Hungary,
suppresses one existing ESE sequence and creates two new
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TABLE 2. PRIMER SEQUENCES FOR THE AMPLIFICATION OF THE CODING REGION OF DFNB31.
Primer name Sequence (5′-3′) Annealing temperature
Exon 1 F: CAGCAGCCAACTCTTGTGTC 55 °C
R: CCAGAAAGGCCAAGTGATTC
Exon 2 F: ACTCCCCAAATCCAAGTTCC 58 °C
R: CAGAACCAGCCTCTTCTTGC
Exon 3 F: CTCCTTGCCAGTCGGATAAG 55 °C
R: GAGTGCTGATTGCTCTGCTG
Exon 4 F: ATAAGGGGACCCTTGGAATG 55 °C
R: TCCCCACTTTTTGGATGAAG
Exon 5 F: GTCCGGAGTTTCCTTTACCC 55 °C
R: TGGTCTGCTCTGTTCATTGC
Exon 6 F: TGGCAATGAACAGAGCAGAC 58 °C
R: GGAGGGCTTGTGAAGATGAC
Exon 7 F: GACAGGGAAGCAGGAGTGAG 58 °C
R: GATTCGAACTCAGGCTGGTC
Exon 8 F: CAGCATCTCTGGCAGTTCAG 58 °C
R: GGCTGTCATGGAGAGGAGAG
Exon 9 F: GTGACAAGCTCTGGCTGATG 58 °C
R: TTCAAACTGGGGTCTCCAAC
Exon 10 F: GGTCTGGTTGAAAGGACAGG 58 °C
R: GGCCTCCAGATTCCTAATCC
Exon 11 F: GAGGCTGAGATTGGTCTTGG 55 °C
R: CCTAGGTCTGCCCTTGAGTG
Exon 12 F: CCCTTTCTCAGCATCTCCAG 58 °C
R: GTCTGCCTTGTCCTGCTCTC
Amplification conditions were 95 °C 5 min followed by 35 cycles of 30 s at 95 °C, 30 s at an annealing temperature specific
for each exon (column 3) and 30 s at 72 °C.T
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498putative ESE sites. The remaining variants were not found to
affect any ESE site.
These changes were also analyzed with NNSPLICE and
Splice  View,  but  neither  was  found  to  affect,  create,  or
eliminate any donor or acceptor splice site.
Intronic changes: All intronic variants were detected in
frequencies ≥0.01, except for c.619–41A>G, c.837+41A>G,
c.1203+114C>T,  c.1416+62delC,  c.2237–44C>T
(rs766835), c.2419–16T>C, and c.2644–157C>T (Table 3).
None of these changes were predicted to affect or create splice
donor  or  splice  acceptor  sites  in  the  analysis  with  the
NNSPLICE and Splice View programs.
DISCUSSION
To  date  only  one  Usher  family  with  clearly  pathogenic,
truncating, DFNB31 mutations has been described [14]. Here,
we describe additional sequence variants in USH patients
tested for mutations in DFNB31 and discuss their putative
pathologic effects.
A total of 38 different variants were found in the DFNB31
sequence,  but  no  variant  was  a  frameshift  or  a  nonsense
change. Out of these, 19 rare variants were found with allelic
frequency ≤0.01; two of them were located in PDZ protein
domains (p.R350W and p.R882S), and four were predicted to
create  or  abrogate  splice  sites  (c.2307C>T,  p.T383N,
p.D447H, and p.R882S).
By the introduction of p.R350W and p.R882S, uncharged
amino acids may affect the three-dimensional structure of the
protein,  which  is  important  for  the  adequate  function  of
interacting domains. Furthermore, both the amino acids R350
and  R882  were  well  conserved  throughout  evolution,
indicating these residues have an important role in protein
structure and function. All these factors point to a possible
pathologic effect for these two variants.
Segregation  analysis  for  the  variants  p.R350W,
p.G769G, p.T383N, and p.D447H could not be performed. In
some cases, we only had a DNA sample from a patient without
any family history. In other cases, the patient was a sporadic
case and segregation analysis did not reveal any information
about the pathogenicity of the variant (e.g., in the case of
p.R882S). We found variant p.R882S in a sporadic Spanish
USH2 patient together with the variant p.S648Y. Segregation
analysis for these changes was performed in healthy relatives
and revealed that both variants were located on the same allele.
In addition, p.R882S and p.S648Y were present in the patient,
in  his  healthy  brother  and  sister,  and  in  his  two  healthy
children.
To explore the possibility of yet unidentified exons of
DFNB31, which may contain mutations in the second allele
of patients with a potentially pathogenic mutation on one
allele,  we  performed  an  in  silico  search  by  using  Geneid
(Genome Bioinformatics Research Lab; Center for Genomic
Regulation,  Barcelona,  Spain),  N-SCAN  (Computational
Genomics Laboratory; Washington University of St. Louis,
St. Louis; MO) and we also searched in the UCSC Genome
Browser  (University  of  California  Santa  Cruz  Genome
Bioinformatics Web Site, Santa Cruz, CA), but no additional
exons were predicted in the DFNB31 locus.
In summary, this study did not reveal evidence for the
involvement of DFNB31 mutations in 195 unrelated USH
patients.  However,  total  or  partial  gene  deletions  and
duplications can escape the screening method applied herein
and therefore cannot be excluded. Our results indicate a minor
causative role for DFNB31 in Usher syndrome. However,
modifying effects of the variants we detected might contribute
to the phenotype of Usher syndrome.
Regarding the implication of this gene in nonsyndromic
hearing loss, the studies performed so far also indicate that
DFNB31 is a rare form of deafness [15,20]. We previously
hypothesized that DFNB31 mutations may also be causative
for nonsyndromic retinal degenerations. This remains to be
confirmed.
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